Nihon Kohden (OTCMKTS:NHNKY) Shares Up 4% - Time to Buy?

Key Points

• Shares were up about 4% to $9.78 on Friday, but trading was extremely light (~797 shares, down 97% vs. average) and the stock remains below its 50-day ($10.99) and 200-day ($11.18) moving averages.
• UBS upgraded Nihon Kohden to a strong-buy, and MarketBeat shows a consensus rating of Strong Buy, signaling positive analyst sentiment.
• Fundamentals: market cap ~$1.66 billion, P/E of 19.06, last quarter EPS $0.16 on revenue of $362.86 million, with a return on equity of 7.25% and net margin of 5.32%.

Nihon Kohden Corporation (OTCMKTS:NHNKY - Get Free Report)'s share price was up 4% during mid-day trading on Friday . The company traded as high as $9.94 and last traded at $9.78. Approximately 797 shares changed hands during mid-day trading, a decline of 97% from the average daily volume of 29,036 shares. The stock had previously closed at $9.40.

Wall Street Analysts Forecast Growth

Separately, UBS Group upgraded Nihon Kohden from a "hold" rating to a "strong-buy" rating in a research report on Monday, January 19th. One investment analyst has rated the stock with a Strong Buy rating, According to MarketBeat.com, the stock has a consensus rating of "Strong Buy".

Nihon Kohden Price Performance

The company has a market capitalization of $1.66 billion, a price-to-earnings ratio of 19.06 and a beta of 0.39. The firm has a 50-day moving average price of $10.99 and a two-hundred day moving average price of $11.18.

Nihon Kohden (OTCMKTS:NHNKY - Get Free Report) last released its earnings results on Thursday, February 5th. The company reported $0.16 EPS for the quarter. The firm had revenue of $362.86 million for the quarter. Nihon Kohden had a return on equity of 7.25% and a net margin of 5.32%.

About Nihon Kohden

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan's earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company's core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.